Latest Roche News & Updates

See the latest news and media coverage for Roche. We track all announcements, press releases, and industry mentions in real time, all in one place.

Roche

Pharmaceuticals and diagnostics company

roche.com

Headquarters: Switzerland 🇨🇭 , Switzerland
Company type: Public company
Number of employees: 100,000+
Industry: Pharmaceuticals

Last updated Today

Latest news about Roche

In short: Roche achieved several FDA priority reviews for its oncology and rare disease pipelines while launching the AXELIOS 1 DNA sequencer.

Company announcements

July 24 Roche

Roche's Susvimo recommended for EU approval in nAMD

The first continuous delivery treatment offers an alternative to frequent eye injections, maintaining vision with as few as two treatments per year.

July 23 Roche

Roche reports 6% revenue growth in the first half of 2026

Group revenue rose by 6% at constant exchange rates, core earnings per share by 9%.

July 23 Roche

Roche sales up 6% at CER in first half 2026

Core operating profit grew 10% at CER, and the company highlighted positive phase III data for divarasib.

July 15 Roche

Roche announces FDA Priority Review for Gazyva in pMN

If approved, it would be the first FDA-approved therapy for primary membranous nephropathy.

Media coverage

July 30 cash

Roche receives approval in China for eye medication as a pre-filled syringe

The Chinese drug authority (NMPA) has approved the drug for the treatment of wet age-related macular degeneration (AMD), diabetic macular edema, and macular edema resulting from a reti...

July 30 Reuters

Roche sues Biocon over proposed breast-cancer drug copy

Roche's Genentech has sued Indian biopharmaceutical company Biocon in New Jersey federal court, alleging its proposed ‌biosimilar of Genentech's blockbuster breast-cancer drug Perjeta would infringe...

July 30 cash

Roche reportedly sues in the US against Perjeta biosimilar

According to media reports, the pharmaceutical company Roche has filed a lawsuit in the US against the Indian biotech company Biocon.

July 30 Seeking Alpha

Hanover outlines 6.9% Q3 catastrophe load as Roche confirms CEO transition in January

Personal Lines profitability was described as "an excellent current accident year ex-CAT combined ratio of 81.9%"; Farber also cited renewal pricing in the quarter with...

Never miss news about Roche

Track Roche and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.